-----

Welcome to the December 2012 issue of Pharmaceutical Technology Sourcing and Management, Pharmaceutical Technology’s and Pharmaceutical Technology Europe’s information resource on pharmaceutical ingredients, manufacturing, and the supply chain. In this issue, 2012 in review, with a analysis of key events shaping the pharmaceutical industry this year, including approvals of new molecular entities and biologics. And the latest developments from the bio/pharmaceutical industry relating to corporate social responsibility and sustainability.

Global Feature
2012: The Year in Review
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
As this year comes to a close, a look at the key events shaping the pharmaceutical and biopharmaceutical industry in 2012 and what may be on the horizon for 2013.
>> Read More

APIs
The Class of 2012 for New Molecular Entities and Biologics
As 2012 comes to a close, Pfizer leads among Big Pharma companies for FDA approvals of new molecular entities and biologics.
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
>> Read More

Outsourcing
Creating a Holistic Procurement System
Gregg Brandyberry is senior vice-president of FedBid, and formerly senior advisor for A.T. Kearney Procurement and Analytic Solutions
The procurement organization rethinks sourcing for maximum efficiency and results.
>> Read More

CSR and Sustainability Forum
CSR and Sustainability in the News
A roundup of developments in corporate social responsibility (CSR) and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.
>> Read More

Advancing Sustainable Packaging
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management .
MeadWestvaco is recognized at CPhI for its sustainable pharmaceutical packaging.
>> Read More

-----

For the full listing of calendar events, see the Calendar of Events page

December
Dec. 6th, 10:00 AM to 11:15 AM EST

Live Webcast from Pharmaceutical Technology: Accelerate the Development of Challenging Drug Candidates via Crystal Engineering
Learn from leading academic and industry experts, including Prof. Zawarotko, Department of Chemistry at the University of South Florida, and Alfred Lee of Merck & Co., about the basic principles of crystal engineering and the API crystallization process and how it impacts drug development. Dr. P.Y. Chen, Manager of Optiform Technologies at Catalent Pharma Solutions, will discuss the design, execution and selection of the optimal solid form utilizing advanced screening technologies.Register here

Dec. 10th, 11:00 AM to 12:00 PM EST
Live Webcast from Pharmaceutical Technology: Best Practices for Achieving Product Quality in Sterile Manufacturing
This 60-minute webcast will provide practical guidance and insight on the strategies and practices for quality control and assurance in sterile manufacturing, including applying the life-cycle approach under FDA’s Guidance for Industry: Process Validation: General Principles and Practices for process design, process qualification, and continued process verification.
Register here

Dec. 11th, 11:00 AM to 12:00 PM EST
Live Webcast from Pharmaceutical Technology: Overcoming Formulation Challenges of Parenteral Drugs
Learn from leading industry experts on how to overcome formulation challenges for poorly water-soluble or difficult-to-deliver parenteral drugs. Gain insight into drug-delivery approaches and excipient selection for optimal functionality.Register here